← back to search

Pooja Middha

German Cancer Research Center · DE
Area of research
Genetics · Oncology
Research interest
Research interests include BRCA gene mutations in cancer, Genetic Associations and Epidemiology, Cancer Risks and Factors, and Bioinformatics and Genomic Networks.
h-index
17
citations
2,822
works
59
NIH funding
primary concept
email

Recent publications

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer
JAMA Network Open 2025cited by 8position: middledoi
Microvascular Endothelial Cells License APS Vasculopathy Through YAP1- and CCN2-Mediated Signaling
Circulation 2025cited by 5position: middledoi
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Nature Communications 2024cited by 29position: firstdoi
Risk factors for breast cancer subtypes by race and ethnicity: a scoping review
JNCI Journal of the National Cancer Institute 2024cited by 26position: middledoi
Risk factors for breast cancer subtypes by race and ethnicity: A scoping review of the literature
medRxiv 2024cited by 5position: middledoi
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
Breast Cancer Research 2023cited by 11position: firstdoi
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies
JNCI Journal of the National Cancer Institute 2022cited by 50position: middledoi
A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women
Cancer Research Communications 2022cited by 14position: middledoi
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
Scientific Reports 2022cited by 6position: middledoi
Abstract 3670: Systematic literature review of risk factor associations with breast cancer subtypes in women of African, Asian, Hispanic, and European descents
Cancer Research 2022cited by 3position: middledoi
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium
Cancer Epidemiology Biomarkers & Prevention 2021cited by 40position: middledoi
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
British Journal of Cancer 2021cited by 9position: middledoi
Genome-Wide Interaction Analysis of Menopausal Hormone Therapy Use and Breast Cancer Risk Among 62,370 Women
Research Square 2021cited by 1position: middledoi
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk
JNCI Journal of the National Cancer Institute 2020cited by 73position: firstdoi
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Nature Communications 2020cited by 47position: middledoi
Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium
International Journal of Epidemiology 2019cited by 32position: firstdoi
Abstract 620: Evaluating multiple tumor markers in a novel analysis of reproductive factors and breast cancer risk
Cancer Research 2019cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marjanka K. Schmidt · American Cancer Society5 papers (2019–2024)Jenny Chang‐Claude · Centre hospitalier universitaire de Québec5 papers (2019–2024)Montserrat García‐Closas · Commonwealth Education Trust5 papers (2019–2024)Thomas U. Ahearn · Department of Health and Human Services4 papers (2019–2024)Audrey Jung · German Cancer Research Center4 papers (2019–2024) · 3 papers (2022–2024)Elisa V. Bandera · Rutgers, The State University of New Jersey3 papers (2022–2024)Mustapha Abubakar · Center for Cancer Research3 papers (2022–2024)Xiaohong R. Yang · Cancer Genetics (United States)3 papers (2022–2024)Rulla M. Tamimi · Cornell University3 papers (2022–2024)Melissa A. Troester · Department of Health3 papers (2022–2024)Hela Koka · Center for Cancer Research3 papers (2022–2024)Renske Keeman · The Netherlands Cancer Institute3 papers (2022–2024)Alexandra R. Harris · National Institutes of Health2 papers (2024–2024)Gisela Butera · George Washington University2 papers (2024–2024) · 2 papers (2024–2024) · 2 papers (2024–2024)Brittany D. Jenkins · Bloomberg (United States)2 papers (2024–2024)Jamirra Franklin · Center for Cancer Research2 papers (2024–2024)Sabine Behrens · German Cancer Research Center2 papers (2019–2019)